New first-line treatment for patients with metastatic pancreatic cancer
Approved by the Food and Drug Administration on February 13, 2024. NALIRIFOX, a combination chemotherapy for first-line treatment of metastatic pancreatic adenocarcinoma. Dr. Patrick BolandI am a medical oncologist. Gastrointestinal Oncology Program We conduct research at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New Jersey’s leading cancer program and the only National Cancer […]
Cureus Diagnosis and Treatment of Metastatic Colon Cancer During Pregnancy that First Presented as Multiple Liver Masses: A Case …Colorectal cancer (CRC) is the second most common cancer in women in Japan. However, it is rare during pregnancy. 3 hours ago
Cureus Diagnosis and Treatment of Metastatic Colon Cancer During Pregnancy that First Presented as Multiple Liver Masses: A Case …Colorectal cancer (CRC) is the second most common cancer in women in Japan. However, it is rare during pregnancy. 3 hours ago
Study finds black patients with metastatic colorectal cancer have different genetic mutations than white patients
January 16, 2024 In a study of more than 500 people who received standard treatments for advanced colorectal cancer, researchers at the UNC Lineberger Comprehensive Cancer Center found that black patients showed distinctly different patterns of genetic mutations compared to white patients. reported. This finding may reflect environmental exposures common in colorectal cancers that occur […]
Avastin plus chemotherapy for metastatic colorectal cancer increases over time
Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]
Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer
3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]
Patients with metastatic colorectal cancer may continue to benefit from immunotherapy even after treatment is discontinued
Credit: Pixabay/CC0 Public Domain The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression for two years after stopping treatment, a new study reports. There is. Research is published in a diary cancer research communication. ICIs have proven effective against […]
Patients with metastatic colorectal cancer may continue to benefit from immunotherapy even after treatment is discontinued
Credit: Pixabay/CC0 Public Domain The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression for two years after stopping treatment, a new study reports. There is. Research is published in a diary cancer research communication. ICIs have proven effective against […]
Nivolumab and ipilimumab improve PFS in newly diagnosed metastatic colorectal cancer
The combination of nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival (PFS) by blinded independent central review (BICR) compared to the chemotherapy chosen by investigators as front-line treatment for microsatellite patients. resulted in statistically significant and clinically meaningful improvements in Meets one of the two primary endpoints of the Phase 3 CheckMate-8HW study in unstable-high […]
Fecal microbiota transplant increases survival in metastatic colorectal cancer treatment
In a recent study published in e-clinical medicineresearchers are evaluating the use of fecal microbiota transplantation to increase the efficacy of anti-programmed cell death protein 1 (PD-1) therapy for patients with microsatellite-stable metastatic colorectal cancer. study: Fecal microbiota transplantation with tislelizumab and fruquintinib in refractory microsatellite-stable metastatic colorectal cancer: an open-label, single-arm, phase II study […]
Patients with metastatic colorectal cancer may find hope with new FDA-approved treatment
This month brought some hopeful news to those battling metastatic colorectal cancer. The U.S. Food and Drug Administration (FDA) on November 8 approved a new oral drug called Fluzacra (fruquintinib) for the treatment of previously treated patients. metastatic colorectal cancer. Until now, patients with this disease have had limited treatment options, including surgery, chemotherapy, radiation […]